Institution
Indonesian Institute of Sciences
Facility•Jakarta, Indonesia•
About: Indonesian Institute of Sciences is a facility organization based out in Jakarta, Indonesia. It is known for research contribution in the topics: Population & Biology. The organization has 4795 authors who have published 10544 publications receiving 76990 citations. The organization is also known as: Indonesian Institute of Sciences Cibinong, Indonesia.
Topics: Population, Biology, Species richness, Genus, Fermentation
Papers published on a yearly basis
Papers
More filters
TL;DR: The basic understanding and recent development associated with electrokinetic soil flushing, bioremediation, and its combination as innovative hybrid solution for treating hydrocarbon contaminated soil are described.
50 citations
TL;DR: In this article, the performance of diesel engine simulated in 1,000-1,500rpm with 0, 10, 20, 30, 40, 50 and 60 Nm engine loads.
50 citations
TL;DR: The proposed direct EV71 viral particle quantification method can be rapidly performed in real time, with high sensitivity and less labor and without assays or fluorescence.
50 citations
TL;DR: In this paper, the effect of pretreatment process by using diluted acid to oil palm's frond characterization as raw materials in the hydrolysis reaction producing monomer sugars which will be fermented into ethanol.
50 citations
TL;DR: Wang et al. as discussed by the authors provided literature-based evidence of reinfection with SARS-CoV-2, and discussed its implication for COVID-19 vaccine development both from the agent and host points of view.
Abstract: Coronavirus disease 2019 (COVID-19) pandemic continues to constitute a public health emergency of international concern. Multiple vaccine candidates for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have entered clinical trials. However, some evidence suggests that patients who have recovered from COVID-19 can be reinfected. For example, in China, two discharged COVID-19 patients who had recovered and fulfilled the discharge criteria for COVID-19 were retested positive to a reverse transcription polymerase chain reaction (RT-PCR) assay for the virus. This finding is critical and could hamper COVID-19 vaccine development. This review offers literature-based evidence of reinfection with SARS-CoV-2, provides explanation for the possibility of SARS-CoV-2 reinfection both from the agent and host points of view, and discusses its implication for COVID-19 vaccine development.
50 citations
Authors
Showing all 4828 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Katsumi Tsukamoto | 63 | 415 | 14099 |
| Munekazu Iinuma | 51 | 436 | 11236 |
| Jun Aoyama | 37 | 133 | 4174 |
| Danny H. Natawidjaja | 34 | 109 | 5306 |
| Tetsuro Ito | 32 | 108 | 3196 |
| Toshiyuki Tanaka | 31 | 162 | 4356 |
| Teruhiko Yoshihara | 31 | 125 | 2952 |
| Leonardus B.S. Kardono | 29 | 80 | 2424 |
| Suharyo Sumowidagdo | 27 | 100 | 2208 |
| Bambang W. Suwargadi | 27 | 59 | 3072 |
| Mark V. Erdmann | 27 | 110 | 3074 |
| Ahmad Fudholi | 26 | 173 | 3311 |
| Wahyoe S. Hantoro | 26 | 56 | 3296 |
| Muhammad Danang Birowosuto | 25 | 123 | 2061 |
| Kosaku Takahashi | 25 | 80 | 1867 |